Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-07
1997-04-15
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514887, A61K 3170
Patent
active
056209622
ABSTRACT:
Disclosed are topical anti-inflammatory compositions containing 0.1% to 10% by weight of a monogalactosyl dieicosapentaenoyl glycerol having esterified eicosapentaenoic acid residues (MGDG-EPA); anti-inflammatory compositions are formulated using a purified microalgal lipid preparation containing 30% to 100% by weight of MGDG-EPA; methods of making the microalgal lipid preparation; methods of treating inflammation by administering the topical anti-inflammatory compositions to a subject in need thereof.
REFERENCES:
David A. Mannock, et al., "The Physical Properties of Glycosyldiacylglycerols. Calaorimetric Studies of a Homologous Series of 1,2-Di-O-acyl-3-(B-D-glucopyranosyl) sn-glycerols". Biochem. 27:6852-6859 1988.
Rollins John W.
Sundsmo John S.
LandOfFree
Anti-inflammatory compositions containing monogalactosyl dieicos does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory compositions containing monogalactosyl dieicos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory compositions containing monogalactosyl dieicos will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-360814